About RESPINOR
RESPINOR is a company based in Oslo (Norway) founded in 2015. The company has 7 employees as of December 31, 2019. RESPINOR offers products and services including DXT. RESPINOR operates in a competitive market with competitors including Medsensio, Docturnal, Ibrum Technologies, ResApp Health and Tambua Health, among others.
- Headquarter Oslo, Norway
- Employees 7 as on 31 Dec, 2019
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Respinor As
-
Annual Revenue
$1.23 M (USD)271as on Dec 31, 2021
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
European Union
& 1 more
-
Employee Count
7
as on Dec 31, 2019
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RESPINOR
RESPINOR offers a comprehensive portfolio of products and services, including DXT.
Non-invasive ultrasound for monitoring diaphragm in critically ill patients.
People of RESPINOR
Unlock access to complete
Unlock access to complete
Funding Insights of RESPINOR
Investors in RESPINOR
RESPINOR has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for RESPINOR
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RESPINOR
Investment portfolio details for RESPINOR
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RESPINOR
Detailed financials for RESPINOR
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Respinor Comparisons
Peer comparison for RESPINOR
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RESPINOR
RESPINOR operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medsensio, Docturnal, Ibrum Technologies, ResApp Health and Tambua Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Respiratory diagnostics are enhanced via a deep learning platform.
|
|
| Locked | Locked | Locked |
Non-invasive solutions for tuberculosis detection and diagnostics are provided.
|
|
| Locked | Locked | Locked |
Devices for detecting undiagnosed cardiac and respiratory diseases are developed.
|
|
| Locked | Locked | Locked |
Respiratory diseases are diagnosed digitally from cough and breathing sounds.
|
|
| Locked | Locked | Locked |
Software for sound based cardiopulmonary disease diagnosis
|
Detailed competitors of RESPINOR
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Respinor
Complete news archive for RESPINOR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RESPINOR
RESPINOR was founded in 2015 and raised its 1st funding round 1 year after it was founded.
RESPINOR is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.
Trude Tingvoll is the current CEO of RESPINOR.
As of Dec 31, 2019, the latest employee count at RESPINOR is 7.
Annual revenue of RESPINOR is $1.23M as on Dec 31, 2021.
Founded in 2015 and based in Oslo, Norway, RESPINOR operates in the medical technology sector. A device for real-time monitoring of diaphragm movement and condition has been developed, utilizing ultrasound to measure excursion. Feedback on progress reports is delivered to healthcare professionals, supporting diagnosis and decision-making processes in clinical settings.
RESPINOR offers DXT.
RESPINOR has 2 investors. Key investors include European Union, and EIC Fund.